Multiple Sclerosis: Gut Origins and Brain Cell Damage Revealed

Research has identified a specific mechanism by which multiple sclerosis (MS) causes the death of brain cells, linking inflammation to DNA damage. Findings reported by SciTechDaily on April 7, 2026, indicate that inflammation triggers chemical reactions that damage the DNA within brain cells.

This accumulation of DNA damage, described as a DNA damage burden, results in the selective loss of CUX2 neurons. This discovery provides a more detailed understanding of how the disease progresses beyond the traditional focus on myelin damage to include the direct destruction of neuronal cells.

The Role of the Gut-Brain Axis

Concurrent research is examining the role of the gut-brain axis in the development and progression of multiple sclerosis. A review published in Frontiers in Immunology on October 15, 2025, describes the gut-brain axis as a bidirectional communication system between the gut microbiome and the central nervous system (CNS).

This system relies on two primary barriers to maintain health: the blood-brain barrier (BBB) and the intestinal barrier. The research suggests that the interaction between the host immune system and gut microbiota is a key factor in regulating the communication between the brain and the gut.

According to the October 15, 2025, review, an altered state of gut microbiota, known as dysbiosis, can lead to several systemic issues:

• Increased intestinal permeability, often referred to as a leaky gut.
• The promotion of systemic immune responses that target the central nervous system.
• Increased permeability of the blood-brain barrier.

Increased BBB permeability is considered a core mechanism in the pathogenesis of multiple sclerosis, allowing immune cells and other substances to enter the brain and spinal cord more easily.

Immune System Regulation and Dysbiosis

The relationship between the gut and the brain is further detailed in a study published in Molecular Neurobiology on February 11, 2025. This research highlights how the gut microbiome interacts with components of the immune system to regulate the body’s overall immune response.

Gut microbes co-evolved with humans and are essential for maintaining a steady state through various pathways, including immune regulation. When this balance is disrupted, the resulting dysbiosis can induce local intestinal permeability, which then triggers the broader immune responses associated with MS.

The convergence of these findings suggests that MS is not solely a disease of the central nervous system but is influenced by systemic barrier functions. The failure of the intestinal barrier may precede or exacerbate the failure of the blood-brain barrier, creating a pathway for the inflammation that eventually leads to the DNA damage and neuron loss observed in the brain.

Pathophysiological Implications

By identifying CUX2 neuron loss and the influence of the gut-brain axis, researchers are uncovering new targets for potential therapeutic interventions. The understanding that inflammation-induced chemical reactions damage DNA offers a specific biological target for preventing the death of brain cells.

Similarly, the focus on barrier function suggests that stabilizing the gut microbiota or reducing intestinal permeability could potentially mitigate the systemic immune responses that contribute to the breakdown of the blood-brain barrier.

While the link between gut dysbiosis and CNS inflammation is increasingly recognized, the research emphasizes that these are complex, multidirectional interactions. The current evidence points toward a model where the dysfunction of the gut-brain axis serves as a crucial framework for understanding how multiple sclerosis begins, and progresses.